Evidence map›Paper›PMID 39028867›Full record

ArticleCritical care explorations2024

Development and Validation of a Machine Learning COVID-19 Veteran (COVet) Deterioration Risk Score.

Sushant Govindan, Alexandra Spicer, Matthew Bearce, Richard S Schaefer, Andrea Uhl, Gil Alterovitz, Michael J Kim, Kyle A Carey, Nirav S Shah, Christopher Winslow and 8 more

Abstract readValidation Study
In one paragraph

Article in Critical care explorations, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sushant GovindanMInDSET Service Line, Kansas City Veterans Affairs Hospital, Kansas City, MO.
Alexandra SpicerDivision of Allergy, Pulmonary, and Critical Care Division, University of Wisconsin-Madison, Madison, WI.
Matthew BearceMInDSET Service Line, Kansas City Veterans Affairs Hospital, Kansas City, MO.
Richard S SchaeferMInDSET Service Line, Kansas City Veterans Affairs Hospital, Kansas City, MO.
Andrea UhlMInDSET Service Line, Kansas City Veterans Affairs Hospital, Kansas City, MO.
Gil AlterovitzHarvard Medical School, Boston, MA.
Michael J KimOffice of Research and Development, Department of Veterans Affairs, Washington, DC.
Kyle A CareySection of General Internal Medicine, University of Chicago, Chicago, IL.
Nirav S ShahDepartment of Medicine, NorthShore University HealthSystem, Evanston, IL.
Christopher WinslowDepartment of Medicine, NorthShore University HealthSystem, Evanston, IL.
Emily GilbertDepartment of Medicine, Loyola University Medical Center, Maywood, IL.
Anne SteyDepartment of Surgery, Northwestern University School of Medicine, Chicago, IL.
Alan M WeissSection of Critical Care, Baycare Health System, Clearwater, FL.
Devendra AminSection of Critical Care, Baycare Health System, Clearwater, FL.
George KarwayDivision of Allergy, Pulmonary, and Critical Care Division, University of Wisconsin-Madison, Madison, WI.
Jennie MartinDivision of Allergy, Pulmonary, and Critical Care Division, University of Wisconsin-Madison, Madison, WI.
Dana P EdelsonSection of Hospital Medicine, University of Chicago, Chicago, IL.
Matthew M ChurpekDivision of Allergy, Pulmonary, and Critical Care Division, University of Wisconsin-Madison, Madison, WI.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveTo develop the COVid Veteran (COVet) score for clinical deterioration in Veterans hospitalized with COVID-19 and further validate this model in both Veteran and non-Veteran samples. No such score has been derived and validated while incorporating a Veteran sample. DERIVATION COHORT: Adults (age ≥ 18 yr) hospitalized outside the ICU with a diagnosis of COVID-19 for model development to the Veterans Health Administration (VHA) (n = 80 hospitals). VALIDATION COHORT: External validation occurred in a VHA cohort of 34 hospitals, as well as six non-Veteran health systems for further external validation (n = 21 hospitals) between 2020 and 2023. PREDICTION MODEL: eXtreme Gradient Boosting machine learning methods were used, and performance was assessed using the area under the receiver operating characteristic curve and compared with the National Early Warning Score (NEWS). The primary outcome was transfer to the ICU or death within 24 hours of each new variable observation. Model predictor variables included demographics, vital signs, structured flowsheet data, and laboratory values.

resultsA total of 96,908 admissions occurred during the study period, of which 59,897 were in the Veteran sample and 37,011 were in the non-Veteran sample. During external validation in the Veteran sample, the model demonstrated excellent discrimination, with an area under the receiver operating characteristic curve of 0.88. This was significantly higher than NEWS (0.79; p < 0.01). In the non-Veteran sample, the model also demonstrated excellent discrimination (0.86 vs. 0.79 for NEWS; p < 0.01). The top three variables of importance were eosinophil percentage, mean oxygen saturation in the prior 24-hour period, and worst mental status in the prior 24-hour period.

conclusionsWe used machine learning methods to develop and validate a highly accurate early warning score in both Veterans and non-Veterans hospitalized with COVID-19. The model could lead to earlier identification and therapy, which may improve outcomes.

Indexed as

COVID-19Machine LearningVeteransAdultAgedCohort StudiesFemaleHospitalizationHumansIntensive Care UnitsMaleMiddle AgedRisk AssessmentROC CurveUnited States

Identifiers

PMID39028867
PMCPMC11262818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.